You are currently using an unsupported browser which could affect the appearance and functionality of this website. Please consider upgrading to the latest version or using alternatives such as Mozilla Firefox, Google Chrome or Microsoft Edge.

Welcome to this course based on Scientific Impact Paper No. 66: Risk-reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause.

The scope of this guidance includes:

  • use of hormone replacement therapy (HRT) post-removal of fallopian tubes and ovaries, to prevent ovarian cancer in premenopausal, high-risk women
  • ovarian cancer
  • endometrial cancer
  • cervical cancer.

This content includes:

  • an animated summary, which will take you on an illustrated journey through all the recommendations in the paper with supporting evidence
  • a complete audio recording of the Scientific Impact Paper in full for those that like to listen on-the-go or are auditory learners.

Product Details:

Product Name Price
Scientific Impact Paper No. 66: Risk-Reducing Salpingo-Oophorectomy and the use of HRT Below the Age of Natural Menopause - 12 Month Access £25.20